Vitreous and aqueous penetration of orally administered gatifloxacin in humans

被引:65
作者
Hariprasad, SM [1 ]
Mieler, WF [1 ]
Holz, ER [1 ]
机构
[1] Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Houston, TX 77030 USA
关键词
D O I
10.1001/archopht.121.3.345
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To investigate the penetration of gatifloxacin, a novel extended-spectrum fourth-generation fluoroquinolone antibiotic, into the Vitreous and aqueous humor after oral administration. Methods: A prospective, nonrandomized study of 24 consecutive patients scheduled for pars plana vitrectomy between September 2001 and May 2002 at the Cullen Eye Institute. Aqueous, vitreous, and serum samples were obtained and analyzed from 24 patients after administration of two 400-mg gatifloxacin tablets taken 12 hours apart before the operation. Assays were performed using high-performance liquid chromatography. Results: Mean +/- SD gatifloxacin concentrations in serum (n = 23), vitreous (n = 23), and aqueous (n = 11) were 5.14 +/- 1.36 mug/mL, 1.34 +/- 0.34 mug/mL, and 1.08 +/- 0.54 mug/mL respectively. Mean +/- SD sampling times after oral administration of the second gatifloxacin tablet for serum, vitreous, and aqueous were 3.2 +/- 1.0 hours, 4.0 +/- 1.0 hours, and 3.9 +/- 1.1 hours, respectively. The percentages of serum gatifloxacin concentration achieved in the vitreous and aqueous were 26.17% and 21.02%, respectively. Mean inhibitory vitreous and aqueous MIC90 levels were achieved against many pathogens, including Staphylococcus epidermidis, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Propionibacterium acnes, Haemophilus influenzae, Escherichia coli, Bacillus cereus, Proteus mirabilis, and other organisms. Conclusions: Orally administered gatifloxacin achieves therapeutic levels in the noninflamed human eye, and the activity spectrum appropriately encompass the bacterial species most frequently involved in the various causes of endophthalmitis. Because of its broad-spectrum coverage, low MIC90 levels for the organisms of concern, and good tolerability, gatifloxacin represents a major advance in the prophylaxis or treatment of postoperative, posttraumatic, and bleb-associated bacterial endophthalmitis.
引用
收藏
页码:345 / 350
页数:6
相关论文
共 23 条
[1]  
AFFELDT JC, 1987, OPHTHALMOLOGY, V94, P407
[2]   VITREOUS CAVITY PENETRATION OF CEFTAZIDIME AFTER INTRAVENOUS ADMINISTRATION [J].
AGUILAR, HE ;
MEREDITH, TA ;
SHAARAWY, A ;
KINCAID, M ;
DICK, J .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1995, 15 (02) :154-159
[3]   The effect of trauma on the ocular penetration of intravenous ciprofloxacin [J].
Alfaro, DV ;
Hudson, SJ ;
Rafanan, MM ;
Moss, ST ;
Levy, SDP .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1996, 122 (05) :678-683
[4]   POSTTRAUMATIC ENDOPHTHALMITIS - CAUSATIVE ORGANISMS, TREATMENT, AND PREVENTION [J].
ALFARO, DV ;
ROTH, D ;
LIGGETT, PE .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1994, 14 (03) :206-211
[5]  
[Anonymous], 1995, Arch Ophthalmol, V113, P1479
[6]   MICROORGANISMS CULTURED FROM THE ANTERIOR-CHAMBER OF RUPTURED GLOBES AT THE TIME OF REPAIR [J].
ARIYASU, RG ;
KUMAR, S ;
LABREE, LD ;
WAGNER, DG ;
SMITH, RE .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1995, 119 (02) :181-188
[7]   Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin [J].
Bauernfeind, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (05) :639-651
[8]  
BOLDT HC, 1989, OPHTHALMOLOGY, V96, P1722
[9]   Bacterial endophthalmitis prophylaxis for cataract surgery -: An evidence-based update [J].
Ciulla, TA ;
Starr, MB ;
Masket, S .
OPHTHALMOLOGY, 2002, 109 (01) :13-24
[10]   Treatment strategies and visual acuity outcomes in chronic postoperative propionibacterium acnes endophthalmitis [J].
Clark, WL ;
Kaiser, PK ;
Flynn, HW ;
Belfort, A ;
Miller, D ;
Meisler, DM .
OPHTHALMOLOGY, 1999, 106 (09) :1665-1670